Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04955275 · ClinicalTrials.gov registry record · NA

The Efficacy of a Remote Cognitive Remediation Therapy (CRT) Program on Parkinson's Disease

A NA study of Parkinson Disease, sponsored by New York Institute of Technology.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT04955275 is a NA study of Parkinson Disease that has completed, run by New York Institute of Technology. The registered enrollment target is 25 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04955275, a NA study of Parkinson Disease, has completed, sponsored by New York Institute of Technology.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

Purpose/Goal: To determine if a remote computerized cognitive remediation program (CRT) can stabilize or improve cognitive functioning in a group of patients from the New York Institute of Technology Academic Health Care Center with Parkinson's disease (PD) after three months of intervention. Hypothesis: Patients with PD who present with current cognitive deficits will show improvement in such deficits after three months of participation in a remotely supervised structured Cognitive Remediation Therapy Program (CRT) compared to control subjects with PD who receive treatment as usual. Research design: Pilot study. Prospective randomized treatment and control comparison pre-post study.

Conditions Studied

Interventions

  • OTHER Cognitive Remediation Therapy Program (BrainHQ)

Study Locations (1)

New York

  • New York Institute of Technology - Old Westbury

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2021-06-01
Est. Completion 2022-04-01
Phase NA

Sponsor

New York Institute of Technology

49 total trials

What the Registry Record Tells You About NCT04955275

The ClinicalTrials.gov registry entry for NCT04955275 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is New York Institute of Technology, which has 49 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Remediation Therapy Program (BrainHQ) is the first listed.

NCT04955275 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04955275 about?

NCT04955275 is a clinical study titled "The Efficacy of a Remote Cognitive Remediation Therapy (CRT) Program on Parkinson's Disease". Purpose/Goal: To determine if a remote computerized cognitive remediation program (CRT) can stabilize or improve cognitive functioning in a group of patients from the New York Institute of Technology Academic Health Care Center with Parkinson's disease (PD) after three months of intervention. Hypot...

What is the current status of trial NCT04955275?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2021-06-01. Estimated completion is 2022-04-01.

What conditions does trial NCT04955275 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT04955275?

The interventions under investigation include: Cognitive Remediation Therapy Program (BrainHQ) (OTHER).

Who is sponsoring clinical trial NCT04955275?

This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04955275 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.